跳至主要内容
临床试验/NCT01935323
NCT01935323已完成不适用

High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight Adolescents.

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Body Composition as measured by DXA

研究概览

简要总结

6-week, single site, two parallel arm, randomized, controlled trial comparing the effectiveness of a High Intensity Interval Training (HIIT) versus a continuous Moderate Intensity Training (MIT) program on cardiovascular and metabolic health outcomes in overweight adolescent males. HIIT training may be a potent time-efficient strategy to induce similar metabolic and cardiovascular adaptations typically associated with MIT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
17 Years 至 22 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • Ages 17-22
  • BMI (25.0 - 35.0 kg/m2)
  • Interested in improving health and fitness

排除标准

  • Weight loss or gain of >10% of body weight in the past 6 months for any reason.
  • Currently taking medication that suppresses or stimulates appetite.
  • History of prior surgical procedure for weight control or liposuction.
  • Current smoker.
  • Any major disease, including:
  • Active cancer or cancer requiring treatment in the past 2 years (except nonmelanoma skin cancer).
  • Active or chronic infections, including self-reported HIV positivity and active tuberculosis.
  • Diagnosed heart conditions.
  • Uncontrolled hypertension: systolic blood pressure 160 mm Hg or diastolic blood pressure 95 mm Hg on treatment.
  • Gastrointestinal disease, including self-reported chronic hepatitis or cirrhosis, any episode of alcoholic hepatitis or alcoholic pancreatitis within past year, inflammatory bowel disease requiring treatment in the past year, recent or significant abdominal surgery (e.g., gastrectomy).
  • Diagnosed diabetes (type 1 or 2), fasting impaired glucose tolerance (blood glucose 118 mg/dL), or use of any anti-diabetic medications.
  • Conditions or behaviors likely to effect the conduct of the trial: unable or unwilling to give informed consent; unable to communicate with the pertinent clinic staff; unwilling to accept treatment assignment by randomization; current or anticipated participation in another intervention research project that would interfere with the intervention offered in the trial; likely to move away from participating clinics before trial completed; unable to walk 0.25 mile in 10 minutes.
  • Currently taking antidepressant, steroid, or thyroid medication, unless dosage is stable (no change for 6 months).
  • Any active use of illegal or illicit drugs.
  • Excessive alcohol intake defined as an average consumption of 3 or more alcohol containing beverages daily.
  • Unwilling to limit alcohol intake to ≤2 drink per day (one drink = 4 oz. wine, 12 oz. beer, or ½ shot of liquor).
  • Current exerciser (>30 min organized exercise per week).
  • Indication of unsuitability of current health for exercise protocol (PARQ).
  • Any other conditions which, in opinion of the investigators, would adversely affect the conduct of the trial.

结局指标

主要结局

Body Composition as measured by DXA

时间窗: Baseline and 6 weeks

次要结局

  • Ghrelin(Baseline and 6 weeks)
  • Adiponectin(Baseline and 6 weeks)
  • HDL Cholesterol(Baseline and 6 weeks)
  • Body Weight(Baseline and 6 weeks)
  • Blood Pressure(Baseline and 6 weeks)
  • Peak uptake of volume of oxygen(Baseline and 6 weeks)
  • Wingate Cycle test(Baseline and 6 weeks)
  • Body Mass Index(Baseline and 6 weeks)
  • LDL Cholesterol(Baseline and 6 weeks)
  • Triglycerides(Baseline and 6 weeks)
  • Insulin(Baseline and 6 weeks)
  • Leptin(Baseline and 6 weeks)
  • Glucose(Baseline and 6 weeks)
  • Free living energy expenditure as measured by accelerometer(Baseline and 6 weeks)
  • PYY(Baseline and 6 weeks)
  • Protein Carbonyls(Baseline and 6 weeks)
  • Quality & satisfaction with life(baseline & 6 weeks)
  • Rate of perceived exertion during exercise via Borg Scale(baseline and 6 weeks)
  • IL-6(Baseline and 6 weeks)
  • TNF-alpha(Baseline and 6 weeks)
  • Appetite/satiety measures(baseline & 6 weeks)
  • 24-hour dietary recall(pre-baseline, baseline, 6 weeks)
  • Self Motivation Inventory(baseline and 6 weeks)
  • Total antioxidant capacity(Baseline and 6 weeks)
  • Profile of Mood States(baseline & 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Allison, Phd

Principal Investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验

High Intensity Interval Versus Continuous Moderate... | 临床试验